Broad-beta disease versus endogenous hypertriglyceridemia: levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia
- PMID: 166269
- DOI: 10.1016/0026-0495(75)90128-6
Broad-beta disease versus endogenous hypertriglyceridemia: levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia
Abstract
To assess the roles of endogenous and exogenous lipid in the production of the abnormal lipoprotein patterns characteristic of broad-beta desease (with a type IVIII lipoprotein pattern) and endogenous hypertriglyceridemia (with a type IV pattern), oral fat loads (50 g/M-2) were administered to six subjects with broad-beta disease and to eight with endogenous hypertriglyceridemia following at leat 72 hr of 0% fat, 85% carbohydrate isocaloric formula feeding. Total plasma and Sf greater than 400, 100-400, 60-100, 30-60, and 20-30 lipoprotein cholesterol, triglyceride, and phospholipid levels were measured at 0 hr, 6 hr (at or before the peak of alimentary lipemia), and 24 hr following the fat load. Following fat-free feeding the levels and composition of the endogenous Sf greater than 400 lipoproteins were similar in both disorders; whereas total Sf20-400, and most notably, Sf 30-60 and 20-30 levels were increased and enriched in cholesterol in the subjects with broad-beta disease.
Similar articles
-
Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).Metabolism. 1976 Jul;25(7):777-801. doi: 10.1016/0026-0495(76)90149-9. Metabolism. 1976. PMID: 181657 Clinical Trial.
-
The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).J Lab Clin Med. 1975 Aug;86(2):239-52. J Lab Clin Med. 1975. PMID: 168277
-
Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).J Clin Invest. 1970 Oct;49(10):1853-8. doi: 10.1172/JCI106403. J Clin Invest. 1970. PMID: 5460288 Free PMC article.
-
Methods to study postprandial lipemia.Curr Vasc Pharmacol. 2011 May;9(3):302-8. doi: 10.2174/157016111795495567. Curr Vasc Pharmacol. 2011. PMID: 21314627 Review.
-
Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.Pharmacotherapy. 1995 May-Jun;15(3):317-37. Pharmacotherapy. 1995. PMID: 7667166 Review.
Cited by
-
Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.J Clin Invest. 1998 Jul 1;102(1):130-5. doi: 10.1172/JCI2673. J Clin Invest. 1998. PMID: 9649566 Free PMC article.
-
Apolipoprotein E.Mol Cell Biochem. 1982 Jan 16;42(1):3-20. doi: 10.1007/BF00223534. Mol Cell Biochem. 1982. PMID: 7038438 Review. No abstract available.
-
Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.Klin Wochenschr. 1977 Nov 1;55(21):1025-30. doi: 10.1007/BF01489475. Klin Wochenschr. 1977. PMID: 200792
-
Secretion of cholesterol-rich lipoproteins by perfused livers of hypercholesterolemic rats.J Clin Invest. 1979 Aug;64(2):674-83. doi: 10.1172/JCI109508. J Clin Invest. 1979. PMID: 222814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources